rhprg4
Recombinant proteinexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jul 31, 2024 (NCT06495307)
Timeline
Indications
Mechanism of action
- Proteoglycan 4Supplementation
PRG4 supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07118254 | Phase 2 | Sep 17, 2025 | Lubris Bio |
| NCT06520202 | Phase 1/Phase 2 (Phase 2) | Aug 31, 2024 | Lubris Bio |
| NCT06495307 | Phase 1/Phase 2 (Phase 2) | Jul 31, 2024 | Lubris Bio, Sydney Eye Hospital |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Lubris Bio | For profit | 3 | 3 | 1 | 2024 |
| Sydney Eye Hospital | Academic/Hospital | 1 | 0 | 1 | 2024 |
2 organizations
Page 1 / 1